Home / Addiction / upi : declared in Common morning sickness drug may not work
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

upi : declared in Common morning sickness drug may not work

This content may collect you by Jack Oliver

We will quote to you most important and trendy news about Drug of the best health sites Like : “upi” and the most famous medical experts :

daily : 2017-01-04 & on time : 16:11

as mentioned in

Experimental Parkinson’s drug may combat movement difficulties

Experimental Parkinson's drug may combat movement difficulties

image uploaded by “upi” site

TUESDAY, Jan. 3, 2017 — New research suggests that people with Parkinson’s disease may achieve better and more reliable motor control by taking an experimental drug called opicapone alongside the standard medication levodopa.A study of several hundred Parkinson’s patients found that the drug — opicapone — boosts levodopa’s ability to control the motor difficulties associated with Parkinson’s, said study co-author Dr. Patricio Soares-da-Silva.These motor problems include tremors, stiffness, and slowed movement.

about the details read more from here

Common morning sickness drug may not work

Common morning sickness drug may not work

image uploaded by “reuters” site

(Reuters Health) – A pill routinely prescribed for morning sickness may not be an effective nausea remedy, researchers say – although not all doctors agree.The warning comes from researchers who conducted a new analysis of a previously unpublished trial that was used to win marketing approval for the drug in the U.S. and Canada.The drug, pyridoxine-doxylamine, is sold as Diclegis in the U.S. and Diclectin in Canada.

about the details read more from here

Powerful drug for advanced cancers may need less frequent dosing

Powerful drug for advanced cancers may need less frequent dosing

image uploaded by “upi” site

WEDNESDAY, Jan. 4, 2017 — Use of a bone cancer drug once every three months, instead of monthly, does not boost the risk of bone problems over two years, a new study finds.That could reduce side effects from the drug, known as zoledronic acid (Zometa), and increase cost savings, the researchers said.The drug is used to treat the spread of breast cancer, prostate cancer and multiple myeloma to the bone.

about the details read more from here

To follow all the new news about Drug

About admin_health

Check Also

The universal Drug Addiction curing Market Future Demand and Growth test with prediction 2022

Description The Universal Drug Addiction curing Report Offers A Comprehensive Evaluation Of The Universal Drug …